P-glycoprotein expression and prognostic value in acute myeloid leukemia

Haematologica

Volumn 83, Issue 9, 1998, Pages 783-787

  Senent, Leonor ^a   Jarque, Isidro ^a   Martín, Guillermo ^a   Sempere, Amparo ^a   González García, Yolanda ^a   Gomis, Federico ^a   Pérez Sirvent, Mariluz ^a   De La Rubia, Javier ^a   Sanz, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

De novo AML; Induction failure; MDR1; Multidrug resistance; P glucoprotein

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MITOXANTRONE; MONOCLONAL ANTIBODY; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGRESSION; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; STEM CELL TRANSPLANTATION; TREATMENT FAILURE;

ACTUARIAL ANALYSIS; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COHORT STUDIES; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GENES, MDR; HUMANS; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MITOXANTRONE; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PROGNOSIS; REMISSION INDUCTION; TUMOR STEM CELLS;

EID: 0031731764     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aglietta M, De Vincentiis A, Lanata L, et al. Peripheral blood stem cells in acute myeloid leukemia: Biology and clinical applications. Haematologica 1996; 81: 77-92.
2. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 1970; 30:1174-84.
3. Kartner N, Riordan JR, Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983; 221:1285-7.
4. Campos L, Guyotat D, Arquimbaud E, et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79:473-6.
5. Gruber A, Vitols S, Norgren S, et al. Quantitative determination of MDR1 gene expression in leukaemic cells from patients with acute leukaemia. Br J Cancer 1992; 266-72.
6. McKenna SL. Multidrug resistance in leukaemia. Br J Haematol 1997; 96:659-74.
7. Boekhorst PAW, Leeuw K, Schoester M, et al. Predominance of functional multidrug resistance (MDR1) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993; 82:3157-62.
8. Galettis P, Boutagy J, MA DDF. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukemia. Br J Cancer 1994; 70:324-9.
9. Arceci RJ. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993; 81:2215-22.
10. Del Poeta G, Stasi R, Venditti A, et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994; 8:388-94.
11. Ino T, Miyazaki H, Isogai M, et al. Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome. Leukemia 1994; 8:1492-7.
12. Lamy T, Goasguen JE, Mordelet E, et al. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). Leukemia 1994; 8:1879-83.
13. Yates J, Glidewell O, Wiernik P, et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood 1982; 60:454-62.
14. Preisler HD. Failure of remission induction in acute myelocytic leukemia. Med Pediatr Oncol 1978; 4:275-6.
15. Wood P, Burguess R, Macgregor A, Liu Yin JA. P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. Br J Haematol 1994; 87:509-14.
16. Zochbauer S, Gsur A, Brunner R, Kyrle PA, Lechner K, Pirker R. P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia 1994, 8:974-7.
17. Zhou DC, Marie JP, Suberville AM, Zittoun R. Relevance of MDR1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6:879-85.
18. Sato H, Preisler H, Day R, et al. MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol 1990; 75:340-5.
19. Pirker R, Wallner J, Geissler K, et al. MDR 1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 1991; 83:708-12.
20. Stasi R, Del Poeta G, Venditti A, et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood 1994; 83:1619-25.
21. Zochbauer S, Haas OA, Schwarzinger I, Lechner K, Pirker R. Multidrug resistance in acute myeloid leukemia with inversion of chromosome 16 or FAB M4Eo subtype [letter]. Lancet 1994; 344:894.
22. Paietta E, Andersen J, Racevskis J, et al. Significant lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses. Leukemia 1994; 8:968-73.
23. Samdani A, Vijapurkar U, Grimm M, et al. Cytogenetics and P-Glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML). Leuk Res 1996; 20:175-80.
24. Willman CL. Immunophenotyping and cytogenetics in older adults with acute myeloid leukemia: significance of expression of the multidrug resistance gene-1 (MDR1). Leukemia 1996 (Suppl 1):S33-5.
25. Drach D, Zhao S, Drach J, Andreef M. Low incidence of MDR1 expression in acute promyelocytic leukaemia. Br J Haematol 1995; 90:369-74.
26. Marie JP, Zittoun R, Sikic BI. Multidrug resistance (MDR1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78:586-92.
27. Heuvel-Eibrink MM, Holt B, Boekhorst PA, et al. MDR1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia. Br J Haematol 1997; 99:76-83.
28. Del Poeta G, Stasi R, Aronica G, et al. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 1996; 87:1997-2004.